NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Hyderabad's Dedicated Pediatric Cancer Network · NCCN protocols · 11 city centres + 35 partner centres

Best Pediatric Cancer Hospital in Hyderabad — 11 Centres, NCCN Protocols, NABH-Accredited Partners

If you've just been told your child has cancer, the most important first thing to know is this: most childhood cancers are curable. Overall 5-year survival in good centres is around 85%, and for many specific types cure rates exceed 90%. The treatment is intense and may run for years — but the goal is cure. The hospital you choose must have a pediatric oncologist (a children's cancer specialist, not an adult oncologist), a child-friendly facility, and a family support system for the long road ahead.

  • Pediatric oncology-led care — children's cancer specialists, not adult oncologists treating kids on the side
  • Tumour-board review — paediatric-protocol plan with written summary, yours to keep
  • NABH-accredited partners — for paediatric surgery and bone marrow transplant
  • 11 city centres + 35 partner centres — day-care chemotherapy close to home over the long treatment course
4.8 · 800+ Google reviews · 15,000+ patients treated · 1,000+ pediatric cases/year
Limited Slots Today

Discuss Your Child's Case

₹950   Today: FREE  ·  Including free written second opinion

45-min consultation with a senior oncologist
Free written second opinion (worth ₹950)
Confidential. No commitment to start treatment.
or
Call 18002028726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)
The CION Pediatric Cancer Panel

Meet the doctors who'll manage your child's care

Same panel across every centre — paediatric oncology-led, tumour-board governed, family-centred. NABH-accredited partners coordinate paediatric surgery and bone marrow transplant.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation
Why the hospital you choose decides everything

Why the hospital matters more than the building

Most families begin by searching for the best pediatric cancer doctor in Hyderabad. The doctor matters — but pediatric cancer is the kind of cancer where the entire institution matters. Children's cancers are different from adult cancers, in type, biology, and treatment. The most common childhood cancers are blood cancers (leukaemia is the biggest), brain tumours, lymphomas, kidney cancer in young children (Wilms tumour), neuroblastoma in babies, eye cancer (retinoblastoma), and bone and soft tissue cancers. The treatment for each is specific to children, with chemotherapy protocols, doses, and supportive care that are different from anything used in adults. A pediatric oncologist runs this care — not a general medical oncologist with paediatric patients on the side. Around that doctor, the hospital needs a child-friendly ward, paediatric-trained nurses, child life specialists, and a long-term plan for school continuity, family support, and (after cure) decades of follow-up care.

This page gives you an honest framework — eight things that separate hospitals that can manage pediatric cancer well from hospitals that simply offer the service — and explains how CION is built around them. Use the framework on every hospital you shortlist. If a hospital can't answer in writing, it should fall off your list.

Did you know?

Childhood cancer is rare — but when it does occur, the outcomes are generally far better than for adult cancers. Overall 5-year survival for childhood cancer in well-resourced centres is around 85%. For acute lymphoblastic leukaemia (the most common childhood cancer), cure rates exceed 90% in low-risk groups. Hodgkin lymphoma cure rates exceed 95%. Wilms tumour cure rates exceed 90%. Treatment is intense — leukaemia treatment often runs 2–3 years — but the goal for almost every child is cure, not just control. Source: NCI / SIOP childhood cancer survival data.

12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
The 8-criteria decision framework

8 things that make a hospital genuinely the best for pediatric cancer in Hyderabad

These are the eight things that matter most for pediatric cancer. Each is verifiable. Each is non-negotiable. Ask the question, get it in writing, and walk away if you can't.

A pediatric oncology-led team

Children with cancer should be treated by a pediatric oncologist — a children's cancer specialist who has trained specifically in paediatric oncology, distinct from a general medical oncologist who treats adult cancers. Childhood cancers are biologically different, the chemotherapy protocols are different (children tolerate higher doses and recover faster, but the long-term effects matter more because they will live for decades), and the supportive care needs are different. Around the pediatric oncologist, the team needs a paediatric surgical oncologist for solid tumours, a radiation oncologist comfortable with paediatric radiation, paediatric-trained nurses, a child life specialist, a paediatric pharmacist, and a family social worker. Ask for named team credentials in writing.

Walk away if the lead oncologist is not specifically trained in paediatric cancer.

Tumour-board review with pediatric-specific protocols

A pediatric tumour board reviews each child's diagnosis, imaging, and biopsy together. The board confirms the cancer type, decides on the paediatric protocol, plans the treatment intensity based on risk group (most pediatric cancer protocols are risk-stratified — lower-risk children get less intense treatment to reduce long-term effects, while higher-risk children get more intense treatment to improve cure rates), and plans the timing of chemotherapy, surgery, and radiation.

Walk away if treatment is recommended without a documented tumour-board discussion that uses paediatric-specific protocols, not adapted adult protocols.

A child-friendly facility with paediatric ward and play areas

Pediatric cancer treatment runs for many months to years — often involving repeated hospital admissions, daily injections, and long periods spent in the ward or on chemotherapy day-care. The hospital environment matters more for children than for adults. A dedicated paediatric oncology ward separated from adult patients, age-appropriate decoration and equipment, play areas with toys and activities, child life specialists who help children prepare for procedures and manage fear, a parent-stay arrangement (parents staying overnight is standard in paediatric oncology), and facilities like a school room or homework area for older children all matter.

Walk away if children are treated on adult oncology wards without a dedicated paediatric environment.

Imaging and biopsy with paediatric anaesthesia care

Most diagnostic procedures in young children — MRI scans, biopsies, lumbar punctures for leukaemia, port insertion for chemotherapy access — require sedation or general anaesthesia, because children cannot lie still or tolerate procedures the way adults can. This means the hospital needs paediatric anaesthetists comfortable with sedating children safely, the right child-sized equipment, and recovery facilities designed for children. Modern paediatric oncology uses bone marrow biopsy and lumbar puncture as routine procedures that need to be done dozens of times during a leukaemia treatment course — each one should be quick, gentle, and well-managed.

Walk away if paediatric procedures are scheduled without a paediatric anaesthetist.

Day-care chemotherapy with pediatric protocols, close to home

Pediatric cancer treatment is long. Leukaemia treatment runs 2–3 years. Treatment for most solid tumours runs 6–12 months. During this time, your child needs frequent chemotherapy cycles, blood tests, growth monitoring, and clinical review. A network of centres close to home means routine visits don't consume entire days — important when you have a working parent, other children, and a child who needs as much normalcy as treatment allows. Ask: "Where can my child get their chemotherapy cycles close to home?"

Walk away if every visit means a long journey to one campus — that's an unsustainable burden over 2–3 years.

NABH-accredited partners for paediatric surgery and bone marrow transplant

Some pediatric cancers need surgery — Wilms tumour, neuroblastoma, some brain tumours, and others. Surgery in children needs a paediatric surgical oncologist, paediatric anaesthesia, and paediatric intensive care after the operation. Some cancers — certain leukaemias that don't respond fully to chemotherapy, high-risk neuroblastoma, some lymphomas — need bone marrow transplant, where the child's diseased bone marrow is replaced with healthy stem cells (either the child's own, harvested earlier, or from a matched donor). Bone marrow transplant requires a specialised paediatric BMT unit. NABH-accredited partners signal audited surgical and procedural safety.

Walk away if the hospital cannot name the partner facility for paediatric surgery or bone marrow transplant.

Insurance, ArogyaSri, and pediatric cancer support schemes

Pediatric cancer treatment is a long financial commitment, but it is also one of the better-supported categories. ArogyaSri covers a significant portion of childhood cancer treatment for eligible families. Central and state government schemes provide additional support specifically for paediatric cancer. Several NGOs — including the Indian Cancer Society, CanKids, and others — provide support for treatment costs, accommodation for out-of-town families, and nutrition. A good hospital has a social work team that helps families navigate these schemes rather than leaving you to figure it out alone.

Walk away if the hospital cannot name the support schemes available or has no social work team helping families access them.

Family support, school continuity, and late-effects monitoring

Pediatric cancer affects the whole family, not just the child. Parents need time off work, often for long periods. Siblings need attention and explanation. The child needs to keep growing, learning, and developing during treatment. And after treatment ends — because most children are cured — they need long-term follow-up for decades, because some chemotherapy drugs can affect the heart, some can affect hearing, growth can be slowed in some cases, fertility can be affected, and there is a slightly increased risk of second cancers later in life. All of this needs to be monitored as the child grows into adolescence and adulthood. Late-effects monitoring is the part of pediatric cancer care that begins after treatment ends and continues for life.

Walk away if the hospital does not have a long-term survivorship clinic for children who have completed treatment.

Hospital archetype comparison

Cancer-specialty network vs multi-specialty hospital vs Ayurveda — which is right for pediatric cancer?

Hyderabad has all three models. They are not interchangeable. The right one depends on whether you have access to a paediatric oncologist, a child-friendly environment for the long treatment journey, and family support that goes beyond the medical care.

Hospital archetype Strengths for pediatric cancer Trade-offs Best fit for
Dedicated cancer-specialty hospital or network Pediatric oncology-led care. Tumour-board review with paediatric protocols. Day-care chemotherapy close to home for the long treatment course. Established family support and scheme navigation. Partner pathway for paediatric surgery and bone marrow transplant. Major paediatric surgery and bone marrow transplant coordinated through partners. Strong networks solve this with NABH-accredited tie-ups to paediatric centres. Most families — where long-term paediatric oncology coordination, child-friendly environment, family support, and post-treatment follow-up matter as much as the medical treatment.
Multi-specialty general hospital with in-house paediatric oncology In-house paediatric oncology and paediatric surgery teams if available. Single-campus coordination for surgery and intensive care. Late-effects survivorship pathway and family support services vary. Coordination with school and social schemes varies. Patients prioritising single-campus care if — and only if — the hospital has a dedicated paediatric oncology team and child-friendly environment.
Ayurveda hospital Symptom relief and recovery support during chemotherapy. Some families value the holistic framing. Not evidence-based as primary curative treatment. Should never replace or delay paediatric oncology chemotherapy — where time-to-treatment and protocol adherence directly determine cure rates. Strictly as an add-on to allopathic oncology care, and only with the paediatric oncologist's knowledge — many herbal preparations interact with chemotherapy and can cause serious problems in children.

The structurally correct default for most families is a dedicated cancer-specialty hospital or network with NABH-accredited partners for paediatric surgery and bone marrow transplant. This is precisely how CION is built.

Why CION — institutional answer

How CION is built for pediatric cancer at an institutional level

CION is not a single hospital. It is a dedicated cancer-specialty network — 11 centres across Hyderabad and 35+ partner centres across Telangana and Andhra Pradesh — with the same panel of oncologists, the same protocols, and the same tumour-board governance at every site. The network is built around the eight criteria above.

A network architecture, not a building

Hospital infrastructure for pediatric cancer is tiered at CION. Diagnosis, day-care chemotherapy cycles, blood counts and monitoring, growth checks, fever and infection management during chemotherapy, and clinical follow-up happen at the centre nearest your home. Paediatric surgery for solid tumours, bone marrow transplant, and complex paediatric radiation run through NABH-accredited partner hospitals with verified paediatric oncology expertise. The same oncology team that consults at one centre stays with your child across the network.

Diagnosis and biopsy with paediatric anaesthesia

Imaging (CT, MRI, PET-CT) and procedures (bone marrow biopsy, lumbar puncture, port insertion, tumour biopsy) are coordinated with paediatric anaesthetists who specialise in sedating and monitoring children safely. For children with leukaemia, who undergo multiple lumbar punctures and bone marrow tests during their treatment, this is more than a one-time consideration — each procedure should be done quickly, gently, and with as little distress as possible.

Long chemotherapy course, close to home

Pediatric chemotherapy is delivered through all 11 CION centres in Hyderabad, with oncology-trained nurses experienced in handling chemotherapy in children, age-appropriate distraction techniques during infusions, fever and infection protocols (children on chemotherapy are at high risk of infections), and supportive care for nausea and other side effects. For families travelling from elsewhere in Telangana or Andhra Pradesh, partner centres handle routine cycles where possible to reduce travel burden.

Fertility preservation for adolescents

For older children and adolescents, fertility preservation is part of CION's standard pre-treatment counselling. Sperm banking for adolescent boys is a simple option that takes a single visit. Egg or ovarian tissue preservation for adolescent girls is more involved but increasingly available. The conversation happens before the first chemotherapy cycle, not after — because options become limited once treatment starts.

School continuity, family support, and sibling care

School continuity is part of pediatric cancer care at CION. We coordinate with schools for adjusted attendance, support hospital-based teaching during long admissions, and help families plan return-to-school as treatment intensity reduces. Social workers help families with financial planning, accommodation for out-of-town families, and access to support schemes. Siblings of childhood cancer patients are often overlooked — CION's family support pathway includes age-appropriate explanation for siblings and connection to peer support groups.

NABH-accredited partner network for surgery, radiation, and BMT

Where a pediatric cancer case needs surgery for solid tumours (Wilms tumour, neuroblastoma, hepatoblastoma, soft tissue sarcoma, brain tumour), paediatric radiation with appropriate sedation, or bone marrow transplant for high-risk leukaemia or other indications, CION coordinates through NABH-accredited partner hospitals with established paediatric programmes and intensive-care capacity. NABH accreditation ensures audited compliance with patient-safety, infection-control, and clinical-governance protocols — particularly important for children whose immune systems are compromised by chemotherapy.

Long-term survivorship clinic

Most children with cancer are cured — and then live for many decades afterwards. CION's pediatric cancer survivorship clinic provides scheduled monitoring of heart function for children who received certain chemotherapy drugs, hearing assessment for those who received platinum-based drugs, growth and pubertal development monitoring, fertility counselling as the child reaches reproductive age, learning and school performance support, and surveillance for second cancers later in life. The intensity reduces over time but never stops — survivorship is a partnership for life.

Tumour-board governance on every pediatric case

Every pediatric cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board confirms the cancer type and risk stratification, decides on the paediatric protocol, plans the timing of chemotherapy, surgery, and radiation where needed, plans bone marrow transplant referral if indicated, and plans surveillance. The board produces a written summary that becomes part of your child's records — and yours to keep. You can take it to any second opinion, anywhere.

Network proof — outcomes and credentials

CION's institutional numbers — verifiable, not adjectival

Specifics beat vague claims. Here is the verifiable network footprint behind CION's pediatric cancer pathway.

City centres in Hyderabad11
Partner centres across Telangana & Andhra Pradesh35+
Centres with CT, MRI & PET-CT diagnostics6
Day-care chemotherapy infusion baysAll 11 city centres
Cancer specialists on panel17+
Patients treated network-wide15,000+
Pediatric cancer cases managed annually1,000+ / year
Google review rating4.8★ (800+ reviews)
Pediatric surgery & bone marrow transplant partner accreditationNABH-accredited
Family support team and social work navigationIntegrated
Fertility preservation counselling for adolescentsStandard pre-treatment pathway
Long-term survivorship clinic for childhood cancer survivorsAvailable
Tumour-board review on every case (with paediatric protocols)Yes — written summary provided
Written second opinionFree (worth ₹950)
Insurance, ArogyaSri, and paediatric cancer scheme accessYes — empanelled
EMI facility for self-paying familiesAvailable on selected packages
Financial accessibility

Insurance, ArogyaSri, support schemes, and cost transparency

Pediatric cancer is one of the better-supported categories in oncology financially. ArogyaSri covers a significant portion of childhood cancer treatment for eligible families. Several central and state government schemes specifically support paediatric cancer. NGOs including the Indian Cancer Society, CanKids, and others provide additional support for treatment, accommodation, nutrition, and transport. The CION social work team helps families navigate these schemes — you should not have to figure it out alone.

  • ArogyaSri empanelment — eligible families can access state-scheme coverage at empanelled CION centres.
  • Cashless insurance — most major insurers and TPAs are accepted, with pre-authorisation handled by the CION insurance desk.
  • Pediatric cancer support schemes — government and NGO schemes specifically for childhood cancer, navigated by the CION social work team.
  • EMI facility — available for self-paying families on selected treatment packages.
  • Written cost estimate — diagnosis, full chemotherapy course, surgery if needed, bone marrow transplant if indicated, and long-term follow-up are itemised before treatment begins.

Bone marrow transplant in particular has specific scheme rules. The CION insurance and social work desks will confirm coverage, pre-authorisation, and scheme eligibility before your child's treatment begins. Ask for written confirmation.

Talk to a CION pediatric cancer specialist today

Free 45-min consultation. Written second opinion. Tumour-board paediatric-protocol plan. ArogyaSri + scheme navigation included.

or
Call 18002028726

By submitting, you consent to be contacted by CION about your enquiry.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →
Surgery, Chemo & Radiation Done by  Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →
 Successful Radical Thymectomy Done by  Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →
Successful Surgery Done  by Dr. Rajender Byshetty

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →
Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →
Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →
Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →
Successful Chemotherapy Done by Dr. Gundu Naresh

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →
Successful Bone Marrow Transplantation - Neuroblastoma

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →
Successful Surgery & Chemo - Carcinoma of Caecum

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Surgery by Dr. Mohammed Imaduddin

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →
Successful Bone Marrow Transplantation

Successful Bone Marrow Transplantation

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Buccal Mucosa Surgery

Successful Buccal Mucosa Surgery

Watch video →
Successful Complex Surgery Mandibulectomy Reconstruction

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Hospital decision FAQs

Frequently asked questions about choosing a pediatric cancer hospital in Hyderabad

Which is the best pediatric cancer hospital in Hyderabad?

No single hospital is automatically best — and for pediatric cancer, the most important factor is whether the hospital has a pediatric oncologist (a children's cancer specialist, distinct from a general medical oncologist who treats adults), a child-friendly facility with a dedicated paediatric ward, and a long-term family support system that goes beyond the medical treatment. The signals to verify are pediatric oncology-led care, partner pathways for paediatric surgery and bone marrow transplant, fertility counselling for adolescents, school continuity support, and late-effects monitoring for survivors. CION Cancer Clinics meets these criteria with 11 centres across Hyderabad and 1,000+ pediatric cancer cases managed every year.

How do I choose the right pediatric cancer hospital in Hyderabad?

Verify eight things in writing: a pediatric oncology-led team, tumour-board review with paediatric-specific protocols, child-friendly facility with a dedicated paediatric ward and play areas, imaging and biopsy done with paediatric anaesthesia care, day-care chemotherapy with pediatric protocols close to home, NABH-accredited partners for paediatric surgery and bone marrow transplant, insurance and ArogyaSri empanelment plus access to pediatric cancer support schemes, and family support including school continuity, sibling support, and long-term late-effects monitoring.

What is the success rate of pediatric cancer treatment in Hyderabad?

Pediatric cancer outcomes are among the best in oncology. Overall 5-year survival for childhood cancer is approximately 85% in well-resourced centres. For specific types, outcomes are even better: acute lymphoblastic leukaemia (the most common childhood cancer) has cure rates above 90% in low-risk groups, Hodgkin lymphoma above 95%, Wilms tumour (a kidney cancer in children) above 90%, and retinoblastoma above 95%. Treatment is intense — leukaemia treatment often runs 2–3 years and most solid tumours 6–12 months — but the goal for almost every child is cure, not just control. The hospital you choose directly determines whether your child receives a paediatric-specific protocol delivered by a paediatric oncology team.

How much does pediatric cancer treatment cost in Hyderabad?

Costs vary by cancer type and treatment intensity. Indicative ranges: bone marrow biopsy and diagnostic workup ₹25,000–60,000; complete imaging staging (CT, MRI, PET-CT) ₹25,000–50,000; full treatment course for acute lymphoblastic leukaemia over 2–3 years ₹5–15 lakh; surgery for solid tumours like Wilms or neuroblastoma ₹2–5 lakh via NABH-accredited partner; autologous bone marrow transplant ₹12–18 lakh; allogeneic bone marrow transplant ₹18–30 lakh; paediatric radiotherapy course ₹2–4 lakh. Pediatric cancer is one of the better-supported categories financially — ArogyaSri, central and state government schemes, and several NGOs provide significant support for childhood cancer families. CION provides a written treatment plan and itemised cost estimate before treatment begins.

Should I choose a cancer-specialty hospital or a multi-specialty hospital for my child's cancer?

For pediatric cancer, the deciding factor is whether the hospital has a pediatric oncologist (a specialist who treats only children's cancers) and a child-friendly facility for the long treatment journey. A cancer-specialty hospital or network usually offers tighter pediatric oncology coordination, paediatric-trained nursing, child life specialists who help children cope with treatment, established schemes for pediatric cancer financial support, and integrated family support services. A multi-specialty hospital with a strong paediatric oncology unit and partner pathways for paediatric surgery can also work well. The structural fit for most families is the cancer-specialty pathway with NABH-accredited partners for surgery and bone marrow transplant.

Is bone marrow transplant available for pediatric cancers in Hyderabad?

Yes. Bone marrow transplant (also called stem cell transplant) is available in Hyderabad through NABH-accredited partner hospitals with dedicated paediatric BMT units. It is used for certain leukaemias that don't respond fully to chemotherapy, for high-risk neuroblastoma, for some lymphomas, and for selected other indications. Autologous transplant (where the child's own stem cells are used) and allogeneic transplant (where a matched donor's stem cells are used — usually a sibling or unrelated donor from an international registry) are both available. CION coordinates referral to partner BMT centres with the CION oncology team continuing to manage chemotherapy planning and follow-up.

What about my child's schooling during cancer treatment?

School continuity is an important part of pediatric cancer care. For many children, treatment runs for months to years — long enough that disconnection from school and friends becomes its own problem. CION coordinates with families on schooling options including hospital-based teaching during long admissions, structured home schooling during chemotherapy cycles, liaison with the child's school for adjusted attendance and accommodations, and gradual return-to-school planning as treatment intensity reduces. For older adolescents, board exam timing and academic continuity are part of treatment planning.

Will my child be able to have children later in life after cancer treatment?

This is an important question that should be discussed before chemotherapy starts. Some chemotherapy drugs used for childhood cancer can affect future fertility. For older boys, sperm banking before treatment is a simple option that preserves future fertility. For girls, egg or ovarian tissue preservation is more involved but increasingly available, especially for older girls and adolescents. For very young children, preservation options are more limited but the topic is still worth discussing. CION raises fertility preservation with families of older children and adolescents as part of standard pre-treatment counselling and coordinates referral to fertility specialists where requested.

Do pediatric cancer hospitals in Hyderabad accept ArogyaSri and private insurance?

Yes — and pediatric cancer is one of the better-supported categories. ArogyaSri covers a significant portion of childhood cancer treatment for eligible families. Central and state government schemes specifically for paediatric cancer provide additional support. NGOs including the Indian Cancer Society and several childhood cancer foundations provide further financial support for treatment, accommodation for out-of-town families, and nutrition support. Bone marrow transplant in particular has specific scheme rules. CION Cancer Clinics is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs, and the CION social work team helps families navigate the various support schemes.

What about long-term follow-up after my child finishes cancer treatment?

This is one of the most important parts of pediatric cancer care. Children cured of cancer go on to live for many decades — meaning the long-term effects of treatment (on the heart, hearing, growth, fertility, learning, and risk of second cancers later in life) need to be monitored carefully for the rest of their lives. CION's pediatric cancer survivorship pathway includes scheduled cardiac function checks for children who received certain chemotherapy drugs, hearing assessment for those who received specific platinum-based drugs, growth and pubertal development monitoring, learning and school performance support, and surveillance for second cancers. The intensity reduces over time but never stops.

Your child deserves a pediatric-oncology-led plan

Book a free 45-minute consultation with a senior CION pediatric oncologist. Tumour-board reviewed. Written second opinion — yours to keep and take anywhere.

The information on this page is provided for general educational purposes and reflects current clinical practice in pediatric oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific child. Survival statistics cited are population-level estimates and do not predict outcomes for an individual case. Always discuss your child's specific situation with a qualified paediatric oncologist before acting on any information presented here. Last Medically Reviewed: May 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh).

Call now Book free consultation